Pfizer lifts 2024 profit view on cost cuts Pfizer has today lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop in sales for its Covid antiviral treatment and strong demand for pneumonia vaccine. Business • 01 May 24
Pfizer lifts 2024 profit view on cost cuts Pfizer has today lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop in sales for its Covid antiviral treatment and strong demand for pneumonia vaccine. Business • 01 May 24
Pfizer agrees Seagen deal to boost cancer portfolio Pfizer has today struck a roughly $43 billion deal for Seagen to bulk up its cancer treatment portfolio, as the drugmaker braces for a steep fall in Covid-19 product sales and loss of exclusivity for some top sellers. Business • 13 Mar 23
Pfizer agrees Seagen deal to boost cancer portfolio Pfizer has today struck a roughly $43 billion deal for Seagen to bulk up its cancer treatment portfolio, as the drugmaker braces for a steep fall in Covid-19 product sales and loss of exclusivity for some top sellers. Business • 13 Mar 23
